Receive a complete Daily History of this Stock You can receive a complete daily file of this issue since 1970 or stock inception. We will email you the file in ASCII format within a few hours or ordering. Product Details | Order

Business Description
Guidant Corporation pioneers lifesaving technology for cardiac and vascular patients. The Company develops, manufactures and markets a broad array of products and services that enable less-invasive care for some of the most threatening medical conditions. Guidant offers stent systems, implantable defibrillator systems, implantable pacemaker systems, implantable cardiac resynchronization therapy, products for use in less-invasive endovascular procedures, including the treatment of abdominal aortic aneurysms, products to perform cardiac surgery procedures such as Off-Pump Coronary Revascularization with EndoScopic vessel harvesting and intravascular radiotherapy systems for artery disease.

Financial Information
GDT designs, develops, manufactures and markets therapeutic medical devices for the treatment of cardiovascular and vascular diseases. For the six months ended 6/30/02, net sales rose 14% to $1.52 billion. Net income rose 52% to $344.3 million. Revenues benefited from growth in unit volume in the United States and European markets and increased Angioplasty system sales. Earnings reflect a $137.1 million litigation gain, and the absence of $25 million in special charges.